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Metabolism Supports Macrophage 
Activation
P. Kent Langston, Munehiko Shibata and Tiffany Horng*
Department of Genetics and Complex Diseases, Harvard T.H. Chan School of Public Health, Boston, MA, USA
Macrophages are found in most tissues of the body, where they have tissue- and 
context-dependent roles in maintaining homeostasis as well as coordinating adaptive 
responses to various stresses. Their capacity for specialized functions is controlled by 
polarizing signals, which activate macrophages by upregulating transcriptional programs 
that encode distinct effector functions. An important conceptual advance in the field of 
macrophage biology, emerging from recent studies, is that macrophage activation is 
critically supported by metabolic shifts. Metabolic shifts fuel multiple aspects of mac-
rophage activation, and preventing these shifts impairs appropriate activation. These 
findings raise the exciting possibility that macrophage functions in various contexts could 
be regulated by manipulating their metabolism. Here, we review the rapidly evolving field 
of macrophage metabolism, discussing how polarizing signals trigger metabolic shifts 
and how these shifts enable appropriate activation and sustain effector activities. We 
also discuss recent studies indicating that the mitochondria are central hubs in inflam-
matory macrophage activation.
Keywords: macrophage, macrophage metabolism, macrophage activation, immunometabolism, mitochondria, 
electron transport chain, mTOR, AKT
OveRview OF MACROPHAGe ACTivATiOn
Macrophages are activated by various signals to acquire specialized functions (1, 2). During micro-
bial infection, macrophages are activated by pathogen-associated molecular patterns such as LPS 
to an inflammatory phenotype that is characterized by production of inflammatory cytokines and 
induction of antimicrobial activities. In the context of type II immune responses, they are activated 
by the cytokines IL-4 and IL-13 to upregulate tissue repair and immunoregulatory activities. LPS- or 
IL-4-activated macrophages [hereafter referred to as M(LPS) and M(IL-4) macrophages, respec-
tively] (3) have served as a paradigm for studies of macrophage activation and metabolism and will 
be discussed in detail in this review (1, 2).
Polarizing signals upregulate transcriptional programs to enforce macrophage activation (1, 
2). In M(LPS) macrophages, LPS engages TLR4 to trigger a signaling pathway that culminates in 
the activation of transcription factors such as NF-κB and IRFs. This allows for the induction of 
a transcriptional program that encodes hallmark genes such as Il1b, Il6, and TNFa. In M(IL-4) 
macrophages, IL-4 binds the IL-4 receptor to trigger a JAK–STAT pathway that activates STAT6, 
the transcription factor responsible for induction of signature genes such as Retnla, Arg1, and 
Chil3. Macrophages lacking NF-κB or STAT6 (or upstream signaling components) are profoundly 
impaired in M(LPS) and M(IL-4) activation, respectively, underscoring the transcriptional basis of 
macrophage activation (1, 2).
BOX 1 | Glossary of major metabolic regulators and pathways 
discussed in text.
mTOR: mTOR kinase is found in two complexes in mammals, mTORC1 
and mTORC2. Other subunits of these complexes are unique to and define 
the complexes, such as Raptor and Rictor in mTORC1 and mTORC2, 
respectively. mTORC1 links availability of nutrients (in particular amino acids) 
and growth factor signaling to anabolic processes such as macromolecule 
synthesis and nutrient storage in proliferating cells and tumor cells. mTORC2 
phosphorylates and activates Akt and other kinases of the AGC superfamily to 
control metabolism, survival, and cytoskeletal organization.
Akt: Akt kinases regulate cell survival, metabolism, and cytoskeleton. 
Downstream of growth factor receptors and IL-4R, Akt is activated by PI3K 
signaling. This is due, at least in part, to PI3K-mediated activation of mTORC2, 
which critically phosphorylates Akt on S473. Activated Akt phosphorylates the 
TSC complex, a negative regulator of mTORC1, to stimulate mTORC1 activity. 
Therefore, the activities of Akt, mTORC1, and mTORC2 are intricately linked 
in the IL-4 signaling pathway.
AMPK: AMPK is a key regulator of cellular energy homeostasis. In 
response to an increasing ADP to ATP ratio, AMPK stimulates ATP generating 
processes (e.g., fatty acid oxidation) while inhibiting non-critical ATP consu-
ming processes (e.g., lipid synthesis) to restore energy balance.
Glycolysis: glycolysis is the process by which glucose is incompletely oxi-
dized in the cytosol, yielding lactate as its final product. Compared to oxidative 
metabolism, glycolysis is fast but energy inefficient.
Pentose phosphate pathway: this is a shunt of glycolysis that produces 
NADPH, important for maintaining cellular redox balance, and nucleotides.
Hexosamine pathway: this is a glycolytic shunt that produces UDP-
GlcNAC, the metabolic substrate for N-glycosylation and O-GlcNAcylation 
modifications of proteins.
TCA cycle: carbon substrates such as glucose-derived pyruvate, fatty 
acids, and glutamine can be oxidized in the TCA cycle. This mitochondrial 
process generates the reducing equivalents NADH and FADH2, which fuels 
the electron transport chain (ETC) to generate ATP via oxidative phosphory-
lation. TCA cycle intermediates can also be diverted for other purposes 
(e.g., cytosolic production of Ac-CoA) or serve other cellular functions (e.g., 
regulating the activities of chromatin modifying enzymes).
Ac-CoA: Ac-CoA is a two-carbon metabolite that partitions into two major 
pools in the cell, mitochondrial versus nuclear/cytoplasmic. The latter pool 
contributes to histone acetylation and lipid synthesis and is critically regulated 
by the enzyme Acly, which cleaves mitochondria-derived citrate to produce 
Ac-CoA.
Electron transport chain (ETC): the ETC consists of five complexes and 
two mobile electron carriers embedded in the mitochondrial membrane that 
link oxidation of carbon substrates to ATP production. The ETC couples the 
energy of electron transfer (from NADH and FADH2) to the generation of 
a proton motive force across the inner membrane, which is harnessed by 
complex V to drive ATP synthesis.
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ReGULATiOn OF MeTABOLiC SHiFTS BY 
POLARiZinG SiGnALS
While metabolic shifts are triggered by growth factor signaling 
and nutrient availability in all mammalian cells, polarizing signals 
have a critical and prominent role during macrophage activa-
tion. In addition to the canonical signaling pathways discussed 
above (e.g., NF-κB, JAK–STAT), polarizing signals impinge on 
metabolic signaling pathways, enabling coordinate induction of 
effector activities and the metabolic processes needed to sustain 
those activities.
Metabolic signaling pathways activated by polarizing signals 
include Akt, mTORC1, mTORC2, and AMPK (Box  1). In 
M(IL-4) macrophages, Akt and mTORC1 form a coordinated 
signaling module that is activated by PI3K and mTORC2 (4–6). 
Downstream of LPS/TLR4, Akt can be activated by TBK/IKKe 
in addition to PI3K, and Akt activity can be disassociated 
from mTORC1 activity (7) (Figures 1A,B). Therefore, Akt and 
mTORC1 activities are regulated disparately in M(LPS) and 
M(IL-4) macrophages with the potential for differential control 
of metabolism and function. IL-10, which activates macrophages 
to an anti-inflammatory phenotype, stimulates AMPK activity, 
while LPS signaling diminishes AMPK activation (8).
What are the consequences of regulation of these metabolic 
signaling pathways by polarizing signals? Akt activity drives 
glucose utilization, including aerobic glycolysis as well as glu-
cose oxidation, in LPS-activated DCs and macrophages (7, 9) 
and M(IL-4) macrophages (10). In LPS-activated DCs, glucose 
oxidation supports production of cytosolic Ac-CoA to boost 
phospholipid synthesis, ER and Golgi expansion and secretory 
capacity, and proinflammatory cytokine production (Figure 1A) 
(7). In M(IL-4) macrophages, Akt–mTORC1 activity controls the 
expression and activity of Acly, which cleaves cytosolic citrate to 
produce a nuclear/cytoplasmic pool of Ac-CoA. Such Ac-CoA 
production fuels histone acetylation at a subset of IL-4-inducible 
genes for optimal M(IL-4) activation (Figure 1B) (10). Because 
Ac-CoA production occurs in the context of LPS-inducible 
inflammatory cytokine production and IL-4-inducible gene 
expression, Akt differentially supports the effector activities of 
LPS- and IL-4-activated dendritic cells/macrophages. In LPS-
activated DCs, mTORC1 activity inhibits oxidative metabolism, 
apparently by stimulating production of NO (11), which can 
damage the ETC. Importantly, the relevant metabolic targets of 
Akt, mTORC1, and other metabolic signaling pathways in control 
of macrophage activation remain incompletely characterized and 
represent an important avenue of future investigation.
Consistent with important roles for metabolic signaling 
pathways in regulating activation, pharmacological or genetic 
manipulations of their activity alter macrophage activation (6). 
Blocking Akt, mTORC1, and mTORC2 reduces M(IL-4) activa-
tion, indicating that the activities of the Akt–mTORC1 axis and 
its upstream activator mTORC2 potentiate M(IL-4) activation 
(5, 10, 12). By contrast, AMPK activity limits the inflammatory 
phenotype of M(LPS) macrophages (8). This has led to the pro-
posal that anabolic metabolism, which is regulated by Akt and 
mTORC1 and involves macromolecule synthesis, supports the 
role of macrophages in type I and type II inflammatory responses. 
By contrast, catabolic metabolism, which is coordinated by 
AMPK and involves breakdown of macromolecules, may sustain 
the anti-inflammatory functions of macrophages (13).
Metabolic signaling pathways integrate metabolic cues to con-
trol macrophage activation. The Akt–mTORC1 pathway couples 
amino acid sensing to M(IL-4) activation such that amino acid 
availability increases, while amino acid deficiency reduces IL-4-
inducible gene induction (10, 12). Like block of the Akt–mTORC1 
pathway, loss of Lamtor1, which mediates lysosomal amino acid 
sensing by mTORC1, impairs M(IL-4) activation (12). Therefore, 
physiological activation of metabolic signaling pathways sup-
ports M(IL-4) activation. However, aberrantly elevated mTORC1 
activity (due to genetic deletion of its negative regulator TSC1) 
attenuates M(IL-4) activation by shutting down Akt signaling. 
In this setting, exaggeration of mTORC1-mediated feedback 
FiGURe 1 | Metabolic control of macrophage activation. (A,B) Metabolic signaling pathways are activated by polarizing signals to coordinate metabolic 
support of macrophage activation. Akt is activated by TBK/IKKe in LPS-stimulated dendritic cells (A), while IL-4R signaling impinges on PI3K to activate mTORC2, 
Akt, and mTORC1 in M(IL-4) macrophages (B). One consequence of LPS-mediated Akt activation is increased glucose oxidation. This supports production of 
phospholipids, which allows for expansion of the secretory compartment for elaboration of high levels of proinflammatory cytokines (A). In M(IL-4) macrophages, 
one consequence of Akt–mTORC1 activation is to increase Acly expression and activity. This enhances production of a cytosolic/nuclear pool of Ac-CoA, which 
regulates histone acetylation at a subset of IL-4-inducible genes (B). Note that this figure illustrates what is currently known regarding the major metabolic targets of 
Akt and mTOR in their control of M(LPS) and M(IL-4) activation, and that additional targets will undoubtedly emerge in future studies. (C,D) Metabolic reprograming 
regulates macrophages activation and function. (C) M(LPS) activation is associated with increased aerobic glycolysis to generate high levels of lactate and 
associated with pentose phosphate pathway (PPP) activity to make NADPH and nucleotides. Citrate is used for Ac-CoA and phospholipid production to support 
increased cytokine secretion and also gives rise to the antimicrobial species itaconate. Downregulation of isocitrate dehydrogenase expression (1) and inhibition of 
succinate dehydrogenase by itaconate (2) disrupt the TCA cycle in M(LPS) macrophages, requiring glutaminolysis and the arginosuccinate shunt (not shown) to 
provide α-ketoglutarate (AKG) and fumarate (fum) to replenish the cycle. (D) M(IL-4) activation is associated with increased utilization of glucose, fatty acids, and 
glutamine. Glucose goes to support N-glycosylation through UDP-GlcNAc. Multiple carbon substrates, including glucose, fatty acids, and glutamine, drive increased 
TCA cycle activity to boost histone acetylation. β-Oxidation is fueled by fatty acids that are either imported or synthesized de novo from glucose. Succ, succinate; 
OAA, oxaloacetate.
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inhibition ultimately diminishes Akt activity to impair M(IL-4) 
activation (4). These findings suggest that pathophysiological 
elevation of mTORC1 activity corrupts the ability of metabolic 
signals to appropriately tune macrophage activation.
Polarizing signals can also impinge on transcriptional master 
regulators of metabolism to trigger metabolic shifts. For example, 
the nuclear receptors PPARγ and PPARδ and the transcriptional 
coactivator PGC1β regulate oxidative metabolism and mitochon-
drial biogenesis in multiple contexts. In M(IL-4) macrophages, 
their induction by STAT6 allows for upregulation of oxidative 
metabolism that is apparently needed for optimal activation (14, 
15). The transcription factor IRF4 has also emerged as a target of 
mTORC2 and STAT6 signaling that regulates M(Il-4) activation. 
IRF4 is needed for induction of glycolysis in M(IL-4) mac-
rophages, and upregulation of many glycolytic genes is reduced in 
IRF4-deficient BMDMs (5). In M(LPS) macrophages, increases 
in the protein levels and activity of the transcription factor HIF1α 
underlie upregulation of glycolysis (16). HIF1α is normally an 
unstable protein but becomes stabilized by LPS-triggered altera-
tions to ETC activity that increases mitochondrial ROS (mtROS) 
production (17). Moreover, LPS signaling increases HIF1α activ-
ity by upregulating the PKM2 isoform of pyruvate kinase (18). 
In addition to its role in glycolysis, PKM2 is a HIF1α coactivator, 
which binds to HIF1α to enhance its transcriptional activity.
4Langston et al. Metabolic Support of Macrophage Activation
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Therefore, polarizing signals co-opt the metabolic machinery 
to coordinate metabolic shifts, which are described in more detail 
below.
MeTABOLiC SHiFTS DURinG 
MACROPHAGe ACTivATiOn
Early studies suggested that M(LPS) macrophages preferentially 
use glucose, while M(IL-4) macrophages consume fatty acids. 
M(LPS) macrophages upregulate expression of the glucose 
transporter Glut1 (19), while M(IL-4) macrophages increase 
expression of lipoprotein lipase and CD36, which mediate uptake 
and transport of fatty acids (14). More recent studies indicate 
complexity in fuel utilization, reporting enhanced consumption 
of glucose in M(IL-4) macrophages (5, 10) and of glutamine in 
M(LPS +  IFNg) and M(IL-4) macrophages (20, 21). Below we 
discuss how M(LPS) and M(IL-4) macrophages augment carbon 
substrate utilization to meet increasing bioenergetic and biosyn-
thetic demand and how they direct carbon substrates to different 
metabolic fates to support distinct effector activities.
Glucose Utilization in M(LPS) 
Macrophages
Early studies indicated that avid glucose consumption in LPS-
activated dendritic cells and macrophages sustains high rates 
of aerobic glycolysis, or “Warburg metabolism” (Figure  1C). 
Experimental attenuation of glycolysis reduces inflammatory 
cytokine production and bacterial killing (9, 16), indicating 
that glycolysis is needed for optimal elaboration of the inflam-
matory phenotype. Mechanistically, how M(LPS) macrophages 
increase glucose utilization and direct glucose carbons into 
aerobic glycolysis are relatively well understood. LPS signaling 
activates Akt to enhance glucose uptake (7), while induction 
of HIF1α, a master regulator of glycolysis, allows for upregu-
lation of multiple genes to stimulate glycolysis. For example, 
upregulation of PFKFB3, a tissue-specific isoform of PFKFB, 
drives overall flux through glycolysis, while induction of PDK1, 
a negative regulator of pyruvate oxidation in the mitochondria, 
and LDHA, the enzyme that converts pyruvate into lactate, 
increases aerobic glycolysis (22, 23). Glycolytic production of 
ATP may be important to fuel optimal induction of effector 
activities and maintain cellular viability, given that oxidative 
metabolism is impaired in M(LPS) macrophages. Glucose 
oxidation is also important in LPS-stimulated dendritic cells 
and macrophages, driving Ac-coA and phospholipid synthesis 
and inflammatory cytokine production as discussed above 
(Figures  1A,C) (7). How glucose oxidation and glycolysis 
are coordinated is incompletely understood but seems to be a 
pivotal node in control of M(LPS) and M(LPS + IFN-g) activa-
tion, as various manipulations that alter this balance perturb 
the activation phenotype (9, 24).
Remarkably, tracing experiments indicate two “breaks” in 
the TCA cycle of M(LPS) and M(LPS +  IFN-g) macrophages 
that alter glucose oxidation with profound consequences for the 
activation phenotype (Figure 1C) (20). The first break regulates 
the fate of the TCA cycle intermediate citrate, which is normally 
converted to α-ketoglutarate by IDH1. In these macrophages, 
downregulation of IDH1, but upregulation of immunorespon-
sive gene 1 (IRG1), an enzyme with decarboxylase activity for 
citrate-derived aconitase, drives the production of itaconate. 
By inhibiting the glyoxylate cycle, a variation of the TCA cycle 
found in microorganisms, itaconate has direct microbicidal 
activity against several pathogens (25). In addition, itaconate 
competitively inhibits succinate dehydrogenase (SDH) in the 
TCA cycle leading to the second “break” (26) (Figure  1C). 
Because SDH is a subunit of complex II (CII) of the ETC, ita-
conate production perturbs ETC activity and oxidative metabo-
lism, and has been linked to regulation of mtROS production 
and inflammatory gene induction (see below). Such inhibition 
of SDH also leads to accumulation of its substrate succinate, of 
note because extracellular succinate can signal through GPR91/
SUCNR1 to regulate dendritic cell migration to draining lymph 
nodes and antigen presentation capacity (27). Therefore, altered 
carbon flow through the TCA cycle critically impacts M(LPS) 
activation.
Arginine, which is a substrate for iNOS in NO production, 
will be discussed briefly here because of its link to the TCA cycle. 
Jha et al. report that in M(LPS +  IFN-g) macrophages, part of 
the TCA cycle is co-opted to form an aspartate–arginosuccinate 
shunt in which aspartate and citrulline are used by argininosuc-
cinate synthase (Ass1) and argininosuccinate lyase (Asl) to 
generate arginine (20). In the context of Mycobacterium infection, 
macrophages initially import extracellular arginine and export 
citrulline (a by-product of arginine metabolism by iNOS) but 
switch to citrulline import for arginine regeneration in this shunt 
only after extracellular arginine becomes depleted. Such import 
of extracellular arginine may allow the macrophages to limit T 
cell responses (28, 29).
Other key nodes in glucose utilization have been shown to 
control M(LPS) activation. M(LPS) macrophages increase flux 
through the pentose phosphate pathway (PPP), a glycolytic 
shunt, by downregulating the sedoheptulose kinase carbohydrate 
kinase-like protein CARKL. This allows for increased produc-
tion of NADPH in the PPP and was proposed to provide redox 
balance in M(LPS) macrophages (Figure  1C). Consistently, 
CARKL knockdown or overexpression perturbed induction of 
LPS-inducible genes (30). NADPH production is also likely to be 
important for fueling the activities of NADPH oxidase and iNOS, 
which produce ROS and NO, respectively, and are important 
components of antimicrobial defense.
Glutamine Utilization in M(LPS) and  
M(iL-4) Macrophages
An important fate of glutamine in M(LPS) and M(IL-4) mac-
rophages appears to be anaplerosis, or refilling of the TCA cycle 
(20, 21). Glutamine-derived carbons enter the TCA cycle as 
α-ketoglutarate, replenishing carbons lost by diversion of citrate 
(Figures 1C,D). In M(IL-4) macrophages, this process has been 
linked to the induction of some IL-4-inducible genes, although 
the underlying mechanisms remain unclear (20). In addition, 
glutamine supplies nitrogen for the hexosamine pathway, a gly-
colytic shunt that produces UDP-GlcNAC. UDP-GlcNAC is the 
FiGURe 2 | Reduced mitochondrial respiration in M(LPS) 
macrophages is due to changes in activities of electron transport 
chain (eTC) complexes. In naïve macrophages, electrons (e−) from 
reducing equivalents such as NADH are transferred between ETC complexes 
via mobile electron carriers and onto oxygen, generating a proton (H+) 
concentration gradient across the inner mitochondrial membrane that powers 
ATP production at complex V. In particular, the mobile electron carrier 
quinone (Q) transfers electrons from complex I (CI) and complex II (CII) to 
complex III, and is oxidized at complex III allowing it to return to CI and CII to 
repeat the cycle. In M(LPS) macrophages, increased production of nitric 
oxide (NO) contributes to impaired respiration. In addition, increased CII 
activity triggering buildup of reduced Q at complex III may provide the 
thermodynamic driving force allowing Q to deliver electrons to CI [reverse 
electron transport (RET)]. Such RET is associated with elevated superoxide 
production ( )O2
−  at CI, leading to stabilization of HIF1α and enhanced Il1b 
expression. Therefore, mitochondrial ETC adaptations underpin M(LPS) 
macrophage effector functions. Cyt c, cytochrome c; succ, succinate; Fum, 
fumarate. Black and red dashed lines indicate forward and reverse electron 
transport respectively.
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substrate for N-glycosylation, and block of this pathway impairs 
cell surface expression of some proteins expressed abundantly in 
M(IL-4) macrophages (Figure 1D) (20).
Glucose Utilization in M(iL-4) 
Macrophages
In M(IL-4) macrophages, enhanced glucose consumption sus-
tains glycolysis as well as glucose oxidation, although the balance 
of these processes is shifted toward oxidation relative to M(LPS) 
macrophages (Figure 1D). Glucose use is stimulated by Akt activ-
ity and IRF4 (5, 10), and fuels Ac-CoA production for histone 
acetylation at IL-4-inducible genes (10) and lipid synthesis (31). 
Glucose utilization also supports UDP-GlcNAC synthesis in the 
hexosamine shunt (Figure 1D) (20).
Fatty Acid Utilization in M(iL-4) 
Macrophages
Early studies implicated fatty acid uptake and oxidation in 
IL-4-inducible gene induction in M(IL-4) macrophages (14). 
More recently, CD36 was shown to play a key role in delivering 
lipoproteins to lysosomes, where breakdown of the cargo by lyso-
somal lipase (LAL) liberates fatty acids that ultimately become 
available for β-oxidation in the mitochondria. This process was 
linked to the induction of several IL-4-inducible genes and mark-
ers and elimination of helminth infection. Intriguingly, fatty acid 
synthesis was also implicated, since blocking fatty acid synthesis 
reduced IL-4-inducible gene induction similar to inhibition of 
LAL or β-oxidation (Figure 1D) (32).
Another recent study identified a protein called FAMIN that 
drives de novo lipogenesis concurrent with fatty acid oxidation 
(31) in M(IL-4) macrophages. Glucose tracing experiments indi-
cate that FAMIN promotes flux of glucose-derived carbons into 
lipogenesis, and that newly synthesized fatty acids are esterified 
to CoA and modified by acyl carnitines suggesting their utiliza-
tion for β-oxidation (Figure  1D). How FAMIN regulates such 
carbon flux remains unknown, but FAMIN interacts with fatty 
acid synthase at peroxisomes. Importantly, FAMIN-deficient 
macrophages have aberrant NLRP3 inflammasome activation 
as well as reduced bacterial killing, which could be a result of 
attenuated mitochondrial and NADPH ROS production and/
or ATP levels (31). Future studies to further characterize how 
fatty acid synthesis and oxidation cycles are regulated and the 
consequences for macrophage activation are warranted.
Cholesterol Metabolism and Type i iFn 
Responses
A recent study indicated an unexpected link between cholesterol 
metabolism and type I IFN signaling (33). In response to type 
I IFN signaling, macrophages increase cholesterol import but 
reduce its biosynthesis. This shift supports IFN-inducible gene 
expression and resistance to viral infection and is coordinated 
by STING, a key regulator of type I IFN signaling. Because it 
resides at the ER where cholesterol is synthesized, STING may 
link sensing of cholesterol biosynthesis to type I IFN responses, 
thus defining a metabolic-inflammatory circuitry that regulates 
antiviral defense (33).
THe MiTOCHOnDRiA AT THe CenTeR OF 
M(LPS) ACTivATiOn
It has long been appreciated that stimulation of macrophages 
and dendritic cells with LPS or LPS + IFNg shuts down oxidative 
metabolism. An underpinning mechanism could be interactions 
of NO with iron–sulfur clusters in the ETC, since iNOS inhibition 
rescues oxidative metabolism (Figure  2) (34, 35). In addition, 
M(LPS) macrophages produce ROS from complex I (CI), which 
has been linked to enhanced bactericidal activity (36). The under-
lying mechanism involved mitochondria-localized interactions 
between TRAF6, a component of the TLR4 signal transduction 
cascade, and ECSIT, a regulator of CI assembly. More recently, a 
flurry of papers has further underscored the connection between 
oxidative metabolism, ETC activity, and inflammatory gene 
induction, thus positioning the mitochondria at the center of 
M(LPS) activation.
The IRG1/itaconate axis appears to play a key role in regu-
lating oxidative metabolism and inflammatory gene induction 
in M(LPS) and M(LPS  +  IFN-g) macrophages (Figure  2). 
As discussed above, induction of IRG1 allows for itaconate 
production and inhibition of SDH (26). Addition of exogenous 
itaconate inhibits oxidative metabolism, while IRG1 deficiency 
enhances oxidative metabolism (37). Importantly, itaconate 
addition inhibits production of IL-6 and IL-12, while IRG1 
6Langston et al. Metabolic Support of Macrophage Activation
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deficiency augments their production (37), suggesting that the 
IRG1/itaconate axis serves as a built-in negative feedback that 
impinges on the ETC to limit excessive inflammatory responses. 
Another recent study also described ETC alterations during E. 
coli infection, specifically a transient increase in CII activity but 
a decrease in CI activity (38). Increased CII activity was trig-
gered by the activities of NADPH oxidase and the Src kinase 
Fgr, which phosphorylates the SDHA subunit of CII. Like the 
other studies, ETC remodeling was linked to inflammatory gene 
induction (38).
How exactly these ETC alterations regulate inflammatory gene 
induction remains unclear. It has been suggested that CII activity 
drives reverse electron transport (RET) to potentiate mtROS pro-
duction and HIF1α stabilization (17) (Figure 2). Increased CII 
activity fuels electron buildup at CIII, providing the thermody-
namic driving force favoring backward electron flow at CI. Such 
RET is associated with mtROS production, which may stabilize 
HIF1α (39) to allow for transcriptional induction of its target 
Il1b (Figure 2) (21). In support of this model, mtROS scavengers 
and pharmacological inhibitors of CII reduce inflammatory 
gene induction (17, 37). Ectopic expression of the mitochondrial 
oxidase AOX, which should alleviate RET by oxidizing excess 
electrons, also recapitulates the phenotype (17). However, ETC 
activities similarly potentiate induction of inflammatory genes 
not thought to be regulated by HIF1α (e.g., Il6), so clarification 
of additional underpinning mechanisms remains an outstanding 
question.
inTeGRATiOn OF MeTABOLiC SiGnALS 
BY CHROMATin
Recent studies indicate that metabolism impinges on chromatin 
for transcriptional control of macrophage activation. Cheng 
et  al. showed that priming with the Candida albicans product 
β-glucan enhances the ability of a subsequent LPS challenge to 
induce genes encoding inflammatory cytokines. This process is 
dependent on Akt and mTORC1 as well as glycolytic activity 
and correlates with chromatin changes at the promoters of these 
genes (40). As discussed above, Covarrubias et al. showed that 
Akt–mTORC1 signaling links amino acid sensing to control of 
Ac-CoA production, histone acetylation, and IL-4-inducible 
gene induction in M(IL-4) macrophages (10). Only a subset of 
IL-4-inducible genes is regulated in this manner, including genes 
controlling cellular proliferation and chemokine production. 
These findings suggest that Akt–mTORC1 signaling couples 
metabolic cues to chromatin to calibrate energetically demanding 
aspects of M(IL-4) activation (10).
FinAL THOUGHTS AnD FUTURe 
DiReCTiOnS
Here, we have focused on how metabolism supports M(LPS) 
and M(IL-4) activation, but macrophages can be activated to 
intermediate states within the M(LPS)-M(IL-4) continuum, or to 
other states by distinct polarizing signals. The focus on M(LPS) 
and M(IL-4) activation is meant to draw a contrast between two 
very different activation phenotypes and their metabolic under-
pinnings, for example, with regard to shut down versus increased 
oxidative metabolism in M(LPS) and M(IL-4) macrophages, 
respectively. In addition to further exploiting the M(LPS)/M(IL-4) 
paradigm to elucidate metabolic underpinnings of macrophage 
activation, future studies should examine additional activation 
states as well as tissue-specific macrophages and macrophages 
from different disease conditions; however, studying metabolism 
in vivo remains a major challenge.
In conclusion, we have highlighted various ways in which 
metabolism underpins macrophage activation. Polarizing signals 
impinge on metabolic signaling pathways, which coordinate 
biosynthetic and bioenergetic support of macrophage activation. 
Metabolic sensing can critically calibrate macrophage activation, 
as illustrated by the ability of the Akt–mTORC1 pathway to 
couple physiological and pathophysiological increases in nutri-
ent availability to differential regulation of M(IL-4) activation, or 
STING to link cholesterol biosynthesis to type I IFN signaling. 
Future studies are expected to highlight the role of mitochondria 
in integrating metabolic cues to TCA cycle and ETC activities for 
control of inflammatory macrophage activation. Future studies 
should also uncover a prominent role for chromatin at the inter-
face of metabolism and transcriptional control of macrophage 
activation.
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